Tern Plc Online Investor Presentation and Q&A Session

Tern Plc (LON:TERN), the company focused on value creation from Internet of Things (“IoT”) technology businesses, has announced that it will be hosting an online presentation and Q&A session at 5.30 p.m. GMT on Tuesday 21 November 2023.

Presenting will be members of Tern’s management team and management from Tern’s portfolio companies Device Authority, Wyld Networks and Talking Medicines. This session is open to all existing and prospective shareholders. Those who wish to attend should register via the following link where they will be provided with access details:

https://us02web.zoom.us/webinar/register/WN_Uouqd7FASNCpmPC1JS1QAQ

Participants will have the opportunity to submit questions for Tern plc during the session, but questions are welcomed in advance and may be submitted prior to 3 p.m. GMT on 21 November 2023 to: tern@investor-focus.co.uk.

Share on:

You might also enjoy reading Tern Plc launches £642k Open Offer at 0.50p per share

Written by: Ethan Davis

Find more news, interviews, share price & company profile here for:
Tern Plc

Latest Company News

Talking Medicines is building the AI layer beneath pharma marketing

December 3, 2025

Talking Medicines is shifting pharma marketing from content creation to data control, building the layer AI tools rely on to deliver credible, measurable clinical messaging.

A shift in how IoT is secured by default

November 28, 2025

KeyScaler 2025 transforms IoT security by automating trust across every device’s lifecycle, from onboarding to decommissioning, turning scalable connectivity and compliance into a built-in feature.

Turning employee sentiment into hard operational data

November 25, 2025

Workforce wellbeing is becoming a source of operational data, and the companies acting early are already reducing risk.

Tern Plc Extends Convertible Loan Maturities in Talking Medicines to Strengthen Exit Strategy

November 25, 2025

Tern Plc extends all convertible loan maturities in Talking Medicines to 2029, enhancing its strategic position for future exit.

A new frontier for medical device trust and patient safety

November 14, 2025

Connected medical device risk is rising and a platform that automates identity, credential and data‑protection lifecycles may become an infrastructure segment worth watching.

When HCP Dialogue Becomes Quantifiable Intelligence

November 11, 2025

Talking Medicines’ DrugVoice platform turns real‑world HCP dialogue into measurable insight, letting brand‑teams forecast message resonance before launch.